BRIEF-Glaxosmithkline Says FDA Approves Expanded Indication For Trelegy Ellipta In The U.S.
April 24, 2018 at 15:15 PM EDT
* FDA APPROVED EXPANDED INDICATION FOR TRELEGY ELLIPTA IN THE U.S. FOR TREATMENT OF PATIENTS WITH COPD Source text for Eikon: Further company coverage:
